| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-10 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.27 | 2e-07 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.27 | 6e-07 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.25 | 7e-07 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.21 | 3e-06 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |